Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Myeloid 1Classical hematology 1

Conditions

Leukemia, Myeloid, Acute 27Anemia, Refractory, with Excess of Blasts 27Myelodysplastic Syndromes 22Myeloproliferative Disorders 14Venous Thromboembolism 13Precursor Cell Lymphoblastic Leukemia-Lymphoma 13Neoplasms 11Lymphoma, Non-Hodgkin 11Leukemia, Myelomonocytic, Chronic 10Anemia 10Primary Myelofibrosis 9Hematologic Neoplasms 9Anemia, Aplastic 9Leukemia, Lymphocytic, Chronic, B-Cell 8Hodgkin Disease 8Thrombocytopenia 7Leukemia, Myelogenous, Chronic, BCR-ABL Positive 7Leukemia 7Fanconi Anemia 7Multiple Myeloma 6Congenital Bone Marrow Failure Syndromes 6Venous Thrombosis 5Pulmonary Embolism 5Myelodysplastic-Myeloproliferative Diseases 5Lymphoma, Follicular 5Febrile Neutropenia 5Anemia, Sickle Cell 5Recurrence 4Leukemia, Myeloid, Accelerated Phase 4Leukemia, Biphenotypic, Acute 4

Interventions

apixaban 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Thrombosis × Classical hematology × 90 days × Clear all
NCT06886516 2026-04-15

Apixaban in Thrombocytopenia

Beth Israel Deaconess Medical Center

Phase EARLY_PHASE1 Recruiting
30 enrolled
Classical hematology

Pulmonary Embolism, Thrombocytopenia, Thromboembolism, Thrombosis, Venous Thrombosis, Venous Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡